Gastroenterologist with IBD focus, Advanced IBD fellow @mayoclinic
Rochester,MN
Joined February 2022
- Tweets241
- Following207
- Followers465
- Likes1.9K
Very proud to see our review on diagnosis and management of CAR-T cell associated enteropathy published! @YiLinMDPhD #CAR-T cell therapy #MayoGIH #immunotherapy
⭐️CAR-T cell therapy can rarely lead to severe gastrointestinal inflammation causing diarrhea and malabsorption, a condition called immune effector cell-mediated enterocolitis. Check out our state-of-the art review!
Highlights below! 🧵
onlinelibrary.wiley.com/doi/…
Navreet Chowla, MD, FACG retweeted
⭐️CAR-T cell therapy can rarely lead to severe gastrointestinal inflammation causing diarrhea and malabsorption, a condition called immune effector cell-mediated enterocolitis. Check out our state-of-the art review!
Highlights below! 🧵
onlinelibrary.wiley.com/doi/…
Hey@ed_bastian @Delta canceling an international flight carrying 500 people because you could not find a crew is unacceptable!! Is this how Delta calls itself #1?? What a joke
Navreet Chowla, MD, FACG retweeted
📢 New pub from #REBOOTIBD consortium and #NorthAmericanpCD group, longer tweet coming from @jalpa_devi
Real-World Effectiveness of Upadacitinib for Perianal Crohn’s Disease: A Multi-Center Retrospective Study - @AGA_CGH in N =125 patients
- 45.5% achieved clinical response,
- 39.4% clinical remission.
- On pelvic MRI (n=78), 55.1% improved and 11.5% completely healed.
- Clinical response higher in anti-TNF–naïve vs. exposed (66.7% vs. 33.3%; p=0.001)
- Clinical response higher in those with shorter disease (54.7% vs. 33.3%; p=0.04) pCD patients
cghjournal.org/article/S1542…
Navreet Chowla, MD, FACG retweeted
I am honored and excited to be co-chair of the Education section of the newly launched ROME Foundation Complementary and Integrative Medicine Section!
Looking forward to working with this amazing team!
@KewinSiah @DrElyseThakur
Endoscopy-related injuries (ERI) are common 🩼🏥Grateful to @MayoClinicGIHep for supporting our grant bringing 🧘♀️ yoga into fellowship training to help reduce ERI. Excited to share our “Ergoyoga” findings at #DDW2026 and spread this innovative practice.
@KhushbooSGala @ShuGI821
Proud to present our work @MayoClinicGIHep CAR-T enteropathy at #DDW2026. 1️⃣predominant duodenal involvement 2️⃣ GVHD-like features 3️⃣ spectrum of lymphoproliferative disease.4️⃣
Multidisciplinary care for GI involvement with cellular therapies.
Navreet Chowla, MD, FACG retweeted
Marina Ivanov, our stellar @MayoClinicGIHep AZ IBD PharmD educating us on understanding hurdles for accessing meds for our patients. Having an IBD PharmD for clinical practice has a huge impact on clinical care. #CCCongress26 @AmerGastroAssn @CrohnsColitisFn
CAR-T/ immune effector enterocolitis at #ACG2025 and the Mayo Cell Therapy & BMT Conference — a reminder that advancing immunotherapy means understanding its GI toxicities too. #MayoClinic #ImmunoTox @MayoClinicGIHep @YiLinMDPhD
American Gastroenterological Association AGA advocacy day on Capitol Hill.
Meeting Senators and congressional representatives. ✅Support NIH funding, ✅relief from prior authorization burden and improve Medicare payments. #agaadvocacy
@VictorChedidMD @BeyderLab @MayoClinicGIHep
Happy to join the membership committee for SAIA ( South Asian IBD alliance), a much needed resource for patients and physicians. Looking forward to connect and share our resources🙏 @ownyourcrohns @ReezwanaCMD
We are so thrilled to kick off our first-ever Membership Committee meeting led by the fabulous @ReezwanaCMD!
Thank you all for joining us & helping us expand SAIA’s outreach globally 🎉🙌🏽
Join us to become a SAIA Member today: saibda.memberclicks.net/new-…
CurQD ( 540-1300 mg Qing Dai and 320-1200 mg curcumin)
@Y_ECCO_IBD #ECCO posters showing benefit in UC and CD
Oral antibody SOR 102 to TNF and IL-23
Phase 1b data presented by @vipuljairath. Promising 💊novel drug for UC!!
#AIBD2024 Always my favorite meeting of the year. Excited to attend, present and spend time with some of amazing colleagues and friends!! @MayoClinicGIHep @NayantaraCoelho
Mayo Clinic GI Hepatology Innovation showcases @IrisWangMD remarkable use of VR in various aspects of patient care.
Mayo GI Hepatology Innovation @VictorChedidMD delivered a great talk on the future of GenAI in GI clinical practice!!
